Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2002-10-02
2011-12-13
Leavitt, Maria (Department: 1633)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S325000, C435S091400, C435S252300, C435S455000, C424S093200
Reexamination Certificate
active
08076100
ABSTRACT:
Nucleic acid constructs containing HIV-1 gag/pol and SIV gag or SIV env genes which have been mutated to remove or reduce inhibitory/instability sequences are disclosed. Viral particles and host cells containing these constructs and/or viral particles are also disclosed. The exemplified constructs and viral particles of the invention may be useful in gene therapy for numerous disorders, including HIV infection, or as a vaccine for HIV-1 immunotherapy and immunoprophylaxis.
REFERENCES:
patent: 5786464 (1998-07-01), Seed et al.
patent: 5795737 (1998-08-01), Seed
patent: 5965726 (1999-10-01), Pavlakis et al.
patent: 5972596 (1999-10-01), Pavlakis et al.
patent: 5994136 (1999-11-01), Naldini et al.
patent: 6114148 (2000-09-01), Seed et al.
patent: 6174666 (2001-01-01), Pavlakis et al.
patent: 6500623 (2002-12-01), Tung
patent: WO 90/11092 (1990-10-01), None
patent: WO 93/20212 (1993-10-01), None
patent: WO 96/09378 (1996-03-01), None
patent: WO 97/11086 (1997-03-01), None
patent: WO 98/12207 (1998-03-01), None
patent: WO 98/17816 (1998-04-01), None
patent: WO 98/34640 (1998-08-01), None
patent: WO 98/46083 (1998-10-01), None
patent: WO 99/04026 (1999-01-01), None
patent: WO 99/15641 (1999-04-01), None
patent: WO 99/30742 (1999-06-01), None
patent: WO 99/51754 (1999-10-01), None
patent: WO 99/61596 (1999-12-01), None
patent: WO 00/39302 (2000-07-01), None
patent: WO 00/39303 (2000-07-01), None
patent: WO 00/39304 (2000-07-01), None
patent: WO 00/65076 (2000-11-01), None
patent: WO-0104360 (2001-01-01), None
Gorelick et al., Strict conservation of the retroviral NC protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant NC zinc-coordinating sequences.Virology, 199, 256: 92-104.
Flint et al., Principles of Virology, molecular biology, pathogenesis and control, 2000 ASM Press, pp. 633-638.
Steffy et al., Genetic regulation of human immunodeficiency virus. Microbiol Rev. 1991, 55:193-205. Review.
Helga-Maria, C et al., An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA.J Virol. 1999 ;73:4127-35.
Fischer, Utz et al., Rev-mediated nuclear export of RNA is dominant over nuclear retention and is coupled to the Ran-GTPase cycle.Nucleic Acids Res. 1999 ;27:4128-34.
Wolff, B et al., Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA Chemm Biol. 1997 ;4:139-47.
Malim et al., The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature. 1989 16;338:254-7.
Gasmi et al., Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors.J Virol. 1999 ;73:1828-34.
Parolin, C et al., Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes.J Virol. 1994 ;68:3888-95.
Rosen, C et al., Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.Proc Natl Acad Sci U S A. 1988 ;85:2071-5.
Kwong, P et al., Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.Nature. 1998 ;393:648-59.
Bowie, j et al., Deciphering the message in protein sequences: tolerance to amino acid substitutions.Science. 1990 ;247:1306-10.
Qiu et al., Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses. J Virol. 1999 ; 73:9145-52.
STIC Protein Search Report. Tracking Title US-10-263-020-1, pp. 1-18.
Rosen CA et al., Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.Proc Natl Acad Sci U S A. Apr. 1988;85(7):2071-5.
Qui JT. Liu B. Tian C. Pavlakis GN. Yu XF. “Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway,” J Virol. Jul. 2000:74(13):5997-6005.
Qiu JT. Song R. Dettenhofer M. Tian C. August T. Felber BK. Pavlakis GN. Yu XF. “Evaluation of novel human immunodeficiency virus type I Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses.” J Virol. Nov. 1999;73(11):9145-52.
T. Maruyama et al.. “Codon usage tabulated from the GenBank genetic sequence data”. Nucl. Acids Res. 14:r151-r197 (1986).
S. Aota et al.. “Codon usage tabulated from the GenBank genetic sequence data”. Nucl. Acids Res. 16:r315-r402 (1988).
Kavita S. Lole, et al., “Full-Length Human Immunodeficiency Virus Type I Genomes from Subtype C-Infected Seroconverters in India. with Evidence of Intersubtype Recombination”. Journal of Virology. 73:152-160 (Jan. 1999) (“Reference 3”).
“Nikkei Biotechnology Annual Report '98”. Ed. Nikkei Biotech. (Nov. 30, 1997). Nikkei Business Publications. Inc., p. 214 (English translation of table on p. 214. lines 30-35 entitled “The recent stream of research and development on AIDS”) (“Reference 4”).
R.I. Connor. et al.. “Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type I while Participating in Trials of Recombinant gp120 Subunit Vaccines”. Journal of Virology. 72:1552-1576 (Feb. 1998) (“Reference 5”).
“Nikkei Biotechnology Annual Report '97”. Ed. Nikkei Biotech. (Nov. 30, 1996). Nikkei Business Publications, Inc., p. 246 (English translation of a table on p. 246. lines 43-46 entitled “The recent stream of biotechnological research on AIDS”) (“Reference 6”).
Ulmer J.B., Donnelly JJ., Parker SE., Rhodes GH., Felgner PI... Dwarki VJ., Gromkowski SH., Deck RR., DeWitt CM., Friedman A., Hawe I.A., Leander KR., Martinez D., Perry HC., Shiver JW., Montgomery DL., Liu MA. “Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein.” Science 259:1745-1748 (Mar. 19, 1993).
Afonina E.. Stauber R.. Pavlakis GN. “The Human Poly( A)-binding Protein I Shuttles between the Nucleus and the Cytoplasm”. The Journal of Biological Chemistry. 273:13015-13021 (May 22, 1998).
Solomin L., Felber BK., Pavlakis GN. “Different Sites of Interaction for Rev. Tev. and Rex Proteins within the Rev-Responsive Element of Human Immunodeficiency Virus Type I”. Journal of Virology. 64:6010-6017 (Dec. 1990).
Schwartz S.. Felber BK., Pavlakis GN., “Distinct RNA Sequences in thegagRegion of Human Immunodeficiency Virus Type 1 Decrease RNA Stability and Inhibit Expression in the Absence of Rev Protein”. Journal of Virology. 66:150-159 (Jan. 1992).
D'Agostino DM.. Felber BK.. Harrison JE.. Pavlakis GN. “The Rev Protein of Human Immunodeficiency Virus Type 1 Promotes Polysomal Association and Translation ofgag/polandvpu/envmRNAs”. Molecular and Cellular Biology. 12:1375-1386 (Mar. 1992).
Zolotukhin AS.. Valentin A.. Pavlakis GN.. Felber BK. “Continuous Propagation of RRE(—) and Rev(—)RRE(—) Human Immunodeficiency Virus Type 1 Molecular Clones Containing acis-Acting Element of Simian Retrovirus Type l in Human Peripheral Blood Lymphocytes”. Journal of Virology. 68:7944.7952 (Dec. 1994).
Tan W., Felber BK.. Zolotukhin AS.. Pavlakis GN.. Schwartz S. “Efficient Expression of the Human Papillomavirus Type 16 1.1 Protein in Epithelial Cells by Using Rev and the Rev-Responsive Element of Human Immunodeficiency Virus or thecis-Acting Transactivation Element of Simian Retrovirus Type 1”. Journal of Virology. 69:5607-5620 (Sep. 1995).
Wolff JA.. Malone RW.. Williams P.. Chong W.. Acsadi G.. Jani A.. Felgner PL. “Direct Gene Transfer into Mouse Muscle in Vivo” Science. 247:1465-1468 (Mar. 23, 1990).
Wolff JA.. Ludtke JJ.. Acsad
Kilpatrick Townsend & Stockton
Leavitt Maria
The United States of America as represented by the Department of
LandOfFree
Molecular clones with mutated HIV gag/pol, SIV gag and SIV... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Molecular clones with mutated HIV gag/pol, SIV gag and SIV..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Molecular clones with mutated HIV gag/pol, SIV gag and SIV... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4298063